Höfundar: Audur Anna Aradottir Pind

The adjuvants dmLT and mmCT enhance humoral immune responses to a pneumococcal conjugate vaccine after both parenteral or mucosal immunization of neonatal mice

The advantages of utilizing heterologous prime-boost strategy in early life vaccination

The adjuvants mmCT and dmLT enhance antibody responses and promote dose sparing of a pneumococcal conjugate vaccine in a neonatal mouse model

Scroll to Top

Á þessu vefsvæði eru notaðar vafrakökur.